| scholarly article | Q13442814 |
| P2093 | author name string | Robert L Fairchild | |
| William M Baldwin | |||
| Anna Valujskikh | |||
| P2860 | cites work | The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages | Q22253155 |
| CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells | Q24310570 | ||
| Platelets amplify inflammation in arthritis via collagen-dependent microparticle production | Q24627618 | ||
| Expression of complement components differs between kidney allografts from living and deceased donors | Q24654702 | ||
| Apoptotic cell clearance: basic biology and therapeutic potential. | Q26825935 | ||
| Monocyte recruitment by HLA IgG-activated endothelium: the relationship between IgG subclass and FcγRIIa polymorphisms | Q27314948 | ||
| Pentraxins (CRP, SAP) in the process of complement activation and clearance of apoptotic bodies through Fcγ receptors | Q27687176 | ||
| Fine-tuning leukocyte responses: towards a chemokine 'interactome' | Q28238676 | ||
| Fcgamma receptors as regulators of immune responses | Q29615584 | ||
| OPTN/SRTR 2012 Annual Data Report: kidney | Q30724491 | ||
| CD40-independent help by memory CD4 T cells induces pathogenic alloantibody but does not lead to long-lasting humoral immunity | Q33603170 | ||
| Contribution of Human FcγRs to Disease with Evidence from Human Polymorphisms and Transgenic Animal Studies | Q33686907 | ||
| Defunctioning polymorphism in the immunoglobulin G inhibitory receptor (FcγRIIB-T/T232) does not impact on kidney transplant or recipient survival | Q34106643 | ||
| Monocyte tethering by P-selectin regulates monocyte chemotactic protein-1 and tumor necrosis factor-alpha secretion. Signal integration and NF-kappa B translocation | Q34218574 | ||
| Is the complement activation product C3a a proinflammatory molecule? Re-evaluating the evidence and the myth | Q34470575 | ||
| Platelet serotonin promotes the recruitment of neutrophils to sites of acute inflammation in mice | Q34513881 | ||
| Early acceptance of renal allografts in mice is dependent on foxp3(+) cells. | Q34805695 | ||
| Platelet chemokines in health and disease. | Q50893679 | ||
| Non-complement- and complement-activating antibodies synergize to cause rejection of cardiac allografts. | Q51038604 | ||
| Circulating NK-cell subsets in renal allograft recipients with anti-HLA donor-specific antibodies. | Q51058705 | ||
| NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in antibody-mediated rejection. | Q51676450 | ||
| Glomerular monocytes predict worse outcomes after acute renal allograft rejection independent of C4d status. | Q51840617 | ||
| Ischemia-reperfusion injury in renal transplantation is independent of the immunologic background. | Q52968716 | ||
| Interpreting NK cell transcripts versus T cell transcripts in renal transplant biopsies. | Q53181446 | ||
| Platelets can enhance vascular permeability | Q57090605 | ||
| Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium | Q57574602 | ||
| Monocytes and peritubular capillary C4d deposition in acute renal allograft rejection11.See Editorial by Colvin, p. 1953 | Q63244408 | ||
| The significance of the anti-class I antibody response. I. Clinical and pathologic features of anti-class I-mediated rejection | Q68704052 | ||
| Pathologic features of acute renal allograft rejection associated with donor-specific antibody, Analysis using the Banff grading schema | Q71157326 | ||
| Induction of cytokine expression in leukocytes by binding of thrombin-stimulated platelets | Q73384671 | ||
| Passive transfer of alloantibodies restores acute cardiac rejection in IgKO mice | Q73823424 | ||
| Murine renal allografts: spontaneous acceptance is associated with regulated T cell-mediated immunity | Q74844325 | ||
| Treatment of early mixed cellular and humoral renal allograft rejection with tacrolimus and mycophenolate mofetil | Q80252616 | ||
| In vivo platelet-endothelial cell interactions in response to major histocompatibility complex alloantibody | Q80763569 | ||
| Platelet factor 4 and interleukin-8 CXC chemokine heterodimer formation modulates function at the quaternary structural level | Q80975325 | ||
| Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence | Q82496190 | ||
| Regulation of anti-HLA antibody-dependent natural killer cell activation by immunosuppressive agents | Q86957441 | ||
| Diagnosis and management of antibody-mediated rejection: current status and novel approaches | Q34841849 | ||
| IFN-γ production by memory helper T cells is required for CD40-independent alloantibody responses | Q34980154 | ||
| Loss of CD11b exacerbates murine complement-mediated tubulointerstitial nephritis. | Q35121838 | ||
| Humoral rejection of human organ transplants | Q35211605 | ||
| Platelets in early antibody-mediated rejection of renal transplants | Q35228522 | ||
| Antibody to human leukocyte antigen triggers endothelial exocytosis | Q35611613 | ||
| Beyond C4d: other complement-related diagnostic approaches to antibody-mediated rejection | Q35666593 | ||
| Disappearance of T Cell-Mediated Rejection Despite Continued Antibody-Mediated Rejection in Late Kidney Transplant Recipients. | Q35790585 | ||
| Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection | Q36317528 | ||
| Kidney transplants in mice. An analysis of the immune status of mice bearing long-term, H-2 incompatible transplants | Q36340245 | ||
| Alloantibody induced platelet responses in transplants: potent mediators in small packages | Q36395085 | ||
| Platelet secretion is kinetically heterogeneous in an agonist-responsive manner | Q36509648 | ||
| Blockade of p-selectin is sufficient to reduce MHC I antibody-elicited monocyte recruitment in vitro and in vivo | Q36584512 | ||
| The classification and treatment of antibody-mediated renal allograft injury: where do we stand? | Q36682686 | ||
| A novel pathway of chronic allograft rejection mediated by NK cells and alloantibody | Q36887068 | ||
| Platelets an inflammatory force in transplantation | Q36967343 | ||
| Anti-huCD20 antibody therapy for antibody-mediated rejection of renal allografts in a mouse model | Q37252758 | ||
| Molecular and functional interactions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseases | Q37307308 | ||
| Platelets influence vascularized organ transplants from start to finish | Q37344903 | ||
| Platelets: active players in the pathogenesis of arthritis and SLE. | Q38032475 | ||
| Antibody-mediated vascular rejection of kidney allografts: a population-based study | Q38062614 | ||
| Platelets: at the nexus of antimicrobial defence | Q38211899 | ||
| Type I and type II Fc receptors regulate innate and adaptive immunity | Q38232105 | ||
| Complement, c1q, and c1q-related molecules regulate macrophage polarization | Q38246272 | ||
| New insights in antibody-mediated rejection | Q38248369 | ||
| Macrophage subsets in atherosclerosis. | Q38264834 | ||
| C4a: An Anaphylatoxin in Name Only. | Q38346764 | ||
| T-cell-mediated rejection of the kidney in the era of donor-specific antibodies: diagnostic challenges and clinical significance | Q38461220 | ||
| The paradoxical roles of C1q and C3 in autoimmunity | Q38498407 | ||
| Characterization of the murine IgG Fc receptor III and IIB gene promoters: a single two-nucleotide difference determines their inverse responsiveness to C5a. | Q40063484 | ||
| Differential and additive effects of platelet-derived chemokines on monocyte arrest on inflamed endothelium under flow conditions | Q40420958 | ||
| Deposition of platelet RANTES triggering monocyte recruitment requires P-selectin and is involved in neointima formation after arterial injury | Q40703820 | ||
| CXC chemokine ligand 4 induces a unique transcriptome in monocyte-derived macrophages | Q41859211 | ||
| Absence of FcγRIII results in increased proinflammatory response in FcγRIII-KO cardiac recipients | Q42633080 | ||
| Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure | Q43918875 | ||
| Acute humoral rejection of renal allografts in CCR5(-/-) recipients | Q46738364 | ||
| Platelet factor 4/CXCL4-stimulated human monocytes induce apoptosis in endothelial cells by the release of oxygen radicals | Q46802145 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 7-14 | |
| P577 | publication date | 2015-11-14 | |
| P1433 | published in | Current opinion in organ transplantation | Q26842426 |
| P1476 | title | Mechanisms of antibody-mediated acute and chronic rejection of kidney allografts | |
| P478 | volume | 21 |
| Q94445562 | Association between transplant glomerulopathy and graft outcomes following kidney transplantation: A meta-analysis |
| Q92182571 | Differences in Pathologic Features and Graft Outcomes of Rejection on Kidney Transplant |
| Q39162642 | Dual Role of Natural Killer Cells on Graft Rejection and Control of Cytomegalovirus Infection in Renal Transplantation. |
| Q91651405 | Generation of hypoimmunogenic human pluripotent stem cells |
| Q61811067 | Germinal Center Alloantibody Responses Mediate Progression of Chronic Allograft Injury |
| Q93006147 | High Pretransplant BAFF Levels and B-cell Subset Polarized towards a Memory Phenotype as Predictive Biomarkers for Antibody-Mediated Rejection |
| Q49297064 | Impact of complement component 3/4/5 single nucleotide polymorphisms on renal transplant recipients with antibody-mediated rejection |
| Q64989685 | Mouse Model Established by Early Renal Transplantation After Skin Allograft Sensitization Mimics Clinical Antibody-Mediated Rejection. |
| Q90602624 | Proteasomal adaptations underlying carfilzomib-resistance in human bone marrow plasma cells |
Search more.